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Abstract
Background
Ischemia/reperfusion (I/R) is an important cause of acute renal failure and delayed graft
function, and it may induce chronic renal damage by activating epithelial to mesenchymal
transition (EMT) of renal tubular cells. Heparanase (HPSE), an endoglycosidase that regu-
lates FGF-2 and TGFβ-induced EMT, may have an important role. Therefore, aim of this
study was to evaluate its role in the I/R-induced renal pro-fibrotic machinery by employing in
vitro and in vivomodels.
Methods
Wild type (WT) and HPSE-silenced renal tubular cells were subjected to hypoxia and reoxy-
genation in the presence or absence of SST0001, an inhibitor of HPSE. In vivo, I/R injury
was induced by bilateral clamping of renal arteries for 30 min in transgenic mice over-
expressing HPSE (HPA-tg) and in their WT littermates. Mice were sacrificed 48 and 72 h
after I/R. Gene and protein EMT markers (α-SMA, VIM and FN) were evaluated by bio-
molecular and histological methodologies.
Results
In vitro: hypoxia/reoxygenation (H/R) significantly increased the expression of EMT-mark-
ers in WT, but not in HPSE-silenced tubular cells. Notably, EMT was prevented in WT cells
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by SST0001 treatment. In vivo: I/R induced a remarkable up-regulation of EMT markers in
HPA-tg mice after 48–72 h. Noteworthy, these effects were absent in WT animals.
Conclusions
In conclusion, our results add new insights towards understanding the renal biological
mechanisms activated by I/R and they demonstrate, for the first time, that HPSE is a pivotal
factor involved in the onset and development of I/R-induced EMT. It is plausible that in
future the inhibition of this endoglycosidase may represent a new therapeutic approach to
minimize/prevent fibrosis and slow down chronic renal disease progression in native and
transplanted kidneys.
Introduction
Ischemia-reperfusion (I/R) injury is a relatively frequent clinical condition following several
local and systemic events characterized by limited tissue perfusion such as delayed graft func-
tion, major vascular surgery complications, trauma and resuscitation, myocardial infarction,
sickle cell disease and acute kidney injury (AKI) [1].
In particular, tissue hypoxia “per-se” and the consequent nutrient reduction cause alteration
of normal cell metabolism/energy homeostasis [2]. As a result, ischemia activates cell death
programs including apoptosis, necrosis and autophagy-associated death [3]. Additionally, the
ischemic period is frequently associated with up-regulation of Toll-Like Receptors (TLRs)
under the control of Hypoxia-inducible factors (HIFs) and NF-kB [4]. Following oxygen reper-
fusion, endogenous ligands from necrotic and apoptotic cells enhance the activation of innate
and adaptive immune cells thus exacerbating the inflammatory tissue and organ injury [5].
As widely demonstrated in the kidney, the clinical consequences of I/R injury may be so
severe to induce AKI and delayed graft function (DGF) in transplantation [6]. Both these
events correlate with the development of tubulointerstitial fibrosis which impacts on long term
function and could be responsible for the development of chronic allograft dysfunction (CAD)
[7]. I/R injury affects mainly tubular and endothelial cells [6]. Hypoxia and hypoxia-generated
reactive oxygen species (ROS) [8] together with pro-fibrotic cytokines and growth factors [9]
activate in tubular cells several signaling programs that alter their physiology, thus sustaining
the fibrotic process [10].
Epithelial-mesenchymal transition (EMT) of renal proximal tubular cells contributes
directly to renal fibrosis [11]. Hypoxia [12] is one of the triggers for EMT such as FGF-2, TGF-
β and ROS [13].
During the transdifferentiation process, renal tubular cells activate genetic programs which
result in the loss of epithelial markers, up-regulation of mesenchymal markers such as vimentin
(VIM), alpha-smooth muscle actin (α-SMA) and fibronectin (FN), loss of cell-cell and cell-
basement membrane contact, and acquisition of a myofibroblast phenotype [12,14].
As demonstrated by our group, heparanase (HPSE) plays an important role in regulating
renal EMT [15]. HPSE is an endoglycosidase that cleaves heparan sulfate (HS) chains and thus
participates in extracellular remodeling [16]. Though HPSE is involved in a number of physio-
logical processes (e.g., embryo implantation, hair growth, tissue repair and inflammatory pro-
cesses) [16], special attention is paid to its involvement in pathological conditions including
tumor progression and renal diseases. A role for HPSE has been identified in several
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proteinuric nephropathies [17–19] mainly in the pathogenesis of diabetic nephropathy (DN)
[20–22] and in a model of septic AKI [23].
Recent studies have shown that HPSE is involved in the development of fibrosis in a DN
mouse model [22]. Moreover, at the molecular level we have demonstrated that this enzyme
may regulate FGF-2- and TGF-β-induced EMT of renal tubular cells [24,25] and that its inhibi-
tion prevents pro-fibrotic events [26].
Applying in vitro and in vivomodels, bio-molecular and histological methodologies, the
present study, focuses on the involvement of HPSE in hypoxia/reoxygenation (H/R)-induced
EMT and its potential therapeutic relevance.
Material and Methods
Cell cultures and treatments
Human renal proximal tubular cell line HK2 (human kidney 2) cells were purchased from
ATCC (CRL-2190™). The cells were grown in DMEM-F12 (EuroClone) (17.5 mM glucose)
supplemented with 10% fetal bovine serum (Biochrom AG), 2 mM L-glutamine, penicillin
(100 U/ml) and streptomycin (100 μg/ml). Cells were cultured at 37°C in a 5% CO2 water-satu-
rated atmosphere to subconfluence and starved for 24 h in serum-free medium. A stably
HPSE-silenced HK2 cell line was obtained by transfection with shRNA plasmid targeting
human HPSE (NM_006665) purchased from OriGene, as previously described [21]. HPSE-
silenced HK2 cells were grown in the same medium of wild-type (WT) HK2 cells supple-
mented with 0.75 μg/ml puromycin. Hypoxic condition was established for 24 h by using an
Anaerob Atmosphere Generation Bags (68061 Sigma Aldrich) and an indicator test for check-
ing the anaerobic conditions (59886 Sigma Aldrich). The system reduces oxygen concentration
below 1% in 1 h without changing the medium pH. Subsequently, the cells were cultured under
normoxic conditions for 6 h (gene expression analysis) or 24 h (protein expression analysis)
(reoxygenation phase) [26]. The cells investigated after a complete cycle of H/R are hereinafter
indicated as H/R cells. Control cells were grown in normoxic conditions for the same time peri-
ods. WT HK2 cells were also treated with or without 200 μg/ml SST0001 (Sigma-Tau Research
Switzerland SA, Mendrisio, CH) both before hypoxia and prior to reoxygenation to mimic a
possible prevention or pharmacological strategy (Fig 1). SST0001 is a modified non anti-coagu-
lant heparin that is 100% N-acetylated and 25% glycol split [27]. Additionally, SST0001 acts by
competing with physiologic heparin for heparanase catalityc site (and allosteric sites) with a
reversible interaction [28,29].
Gene expression analysis
Total RNA was extracted from cell monolayers and from frozen renal tissues using the “Trizol”
reagent (Invitrogen), according to the manufacturer’s instruction. Yield and purity were
checked using Nanodrop (EuroClone) and total RNA from each sample was reverse tran-
scribed into cDNA using SuperScript II Reverse Transcriptase (Invitrogen). Real-time PCR
was performed on an ABI-Prism 7500 using Power SYBR Green Master Mix 2X (Applied Bio-
systems). The comparative Ct method (ΔΔCt) was used to quantify gene expression and the rel-
ative quantification was calculated as 2-ΔΔCt. The presence of non-specific amplification
products was excluded by melting curves analysis. The primers are listed in Table 1.
Western Blotting
Cells from cultures were lysed in RIPA buffer for HIF-1 alpha investigation and in 50 mM
Tris-HCl, pH 5.0, 150 mMNaCl,0.5% Triton X-100 with Complete Protease Inhibitor Mixture
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Fig 1. Schematic representation of in vitro experimental design. Serum starved HK-2 cells were exposed to 24 h of hypoxia and subsequently
to reoxygenation (6 h for gene expression and 24 h for protein expression analysis). Cells were also treated or not with 200 μg/ml SST0001 (red
balls) before the hypoxia (point #4; herein after referred to as H/R1) and before reoxygenation (point #5; herein after called H/R2). Control cells
were cultured in normoxic conditions with or without SST0001 (points #1 and 2).
doi:10.1371/journal.pone.0160074.g001
Table 1. Primers sequence list.
Gene Forward 5’-3’ Reverse 5’-3’
Human
GAPDH ACACCCACTCCTCCACCTTT TCCACCACCCTGTTGCTGTA
HPSE ATTTGAATGGACGGACTGC GTTTCTCCTAACCAGACCTTC
α-SMA GAAGAAGAGGACAGCACTG TCCCATTCCCACCATCAC
FN GTGTGTTGGGAATGGTCGTG GACGCTTGTGGAATGTGTCG
Mouse
GAPDH GGCAAATTCAACGGCACAGT GTCTCGCTCCTGGAAGATGG
HPSE CAAGAACAGCACCTACTCAAG AGCAGTAGTCAAGGAGAAGC
α-SMA TGCTGGACTCTGGAGATGGT ACGAAGGAATAGCCACGCTC
VIM TCCAGAGAGAGGAAGCCGAA AAGGTCAAGACGTGCCAGAG
doi:10.1371/journal.pone.0160074.t001
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(Roche Applied Science) for the other cytoplasmic protein analyses. Briefly, equal amounts of
proteins were treated in reducing sample buffer and denatured for 10 min at 100°C. Protein
samples were then resolved in 10% SDS-PAGE and electrotransferred to nitrocellulose mem-
branes. Non-specific binding was blocked for 1 h at room temperature with non-fat milk (5%)
in TBST buffer (50 mM Tris-HCl, pH 7.4, 150 mMNaCl, 0.1% Tween 20). Membranes were
exposed to primary antibodies directed against GAPDH (Santa Cruz sc-25778), FN (Santa
Cruz sc-9068), α-SMA (Sigma A5228), HPSE (InSight HP130) or HIF-1 alpha (BD 610959),
overnight at 4°C and incubated with a secondary peroxidase-conjugated antibody for 1 h at
room temperature. The signal was detected with SuperSignals West Pico Chemiluminescent
substrate solution (Pierce) according to the manufacturer’s instructions.
Immunofluorescence
Sections (4 μm) were cut from paraffin embedded tissue and non-specific binding sites were
saturated for 1 h at 37°C with PBS, 5% BSA. Sections were incubated at 4°C overnight with pri-
mary antibodies diluted in PBS supplemented with 1% BSA. The primary antibodies used were
directed against VIM (Santa Cruz sc-7557), FN (Santa Cruz sc-9068), α-SMA (Sigma A5228),
or HPSE (Santa Cruz sc-25826). Primary antibodies were revealed with an anti-goat-FITC for
VIM, anti-rabbit-Cy3 for FN and HPSE, and anti-mouse-TR for α-SMA by incubation at
room temperature for 45 min. Cell nuclei were visualized by Hoechst 33258. Images were
obtained with a confocal LeicaSP5 microscope. Image processing was done with Image J
(https://imagej.nih.gov/ij/).
Animal model and induction of renal ischemia
Acute ischemia was induced in WT and heparanase-overexpressing (HPA-tg) [30] Balb/c
mice. The investigation was conducted according to the guidelines of the Animal Use and Care
Committee, Technion (Haifa), and according to the Guide for the Care and Use of Laboratory
Animals (NIH Publication no. 85–23, 1996) as approved by the local committee for supervision
of animal experiments. The Bruce Rappaport Faculty of Medicine, Technion (Haifa, Israel)
Animal Care and Use Committee (IACUC) specifically approved this study.
WT and HPA-tg mice were anesthetized with sodium pentobarbital (50 mg/kg, IP) and
placed on a controlled heating (thermoregulated) table, keeping the body temperature at 37°C.
Both right and left renal arteries were exposed and clamped for 30 min during which time the
kidney was kept warm and moist. The clamp was then removed, the kidney was observed for
return of blood flow, and the abdominal wall incision was sutured. The mice were allowed to
recover in a warmed cage for 48 and 72 h and blood samples were obtained at each time point
for measurement of creatinine. All the mice were sacrificed by CO2 inhalation followed by cer-
vical dislocation. The kidneys were harvested and weighted. One half of the left kidney was
snap-frozen in liquid nitrogen and stored at −70°C until further molecular processing; the
other half was fixed in formalin, paraffin-embedded, and sectioned (4 μm). Paraffin sections
were used for PAS staining. Sham operated mice that underwent an identical procedure except
for renal artery clamping, served as controls.
Statistical Analysis
Mean ± S.D. of the real-time PCR data were calculated with Rest2009 software. Differences
between normoxia and hypoxia or treated and untreated cells were compared using Two-tailed
Student's t-test. A p-value< 0.05 was set as the level of significance for all tests. Gene expres-
sion differences in mouse samples were analyzed by linear regression models with group (WT-
sham, WT-I/R 48h, TG-sham, TG-I/R 48h) entered as a categorical variable. Bonferroni-
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corrected adjusted means and differences were computed using the WT-sham as the referent
group. A Bonferroni-corrected p-value< 0.05 was considered as statistically significant
Results
Hypoxia/Reoxygenation (H/R) increased HPSE expression in renal
tubular epithelial cells
To identify whether H/R was able to modulate HPSE expression in renal tubular epithelial
cells, we used wild type, HPSE-silenced and WT SST0001-treated HK2 cells. SST0001 is a spe-
cific inhibitor of HPSE.
Interestingly, as showed in Fig 2A gene expression analysis revealed that H/R was able to
induce a significantHPSE up-regulation in WT cells, but neither in HPSE-silenced cells nor in
those treated with the specific inhibitor. At protein level (Fig 3A), we found a slight, but not
statistically significant increment of this enzyme after H/R. Notably, treatment of WT cells
with SST0001 reduced HPSE gene expression below basal levels.
These data suggest that HPSE is modulated by H/R and it could be involved in the complex
biological machinery associated with this event.
HPSE-silencing inhibits EMT induced by H/R in renal tubular epithelial
cells
Based on previous literature evidences suggesting a central role of HPSE in the EMT of renal
tubular epithelial cells [15], we decided to measure its contribution in the profibrotic machin-
ery induced by H/R.
To this purpose, major mesenchymal markers of EMT were measured after H/R in wild
type HK2 cells and those silenced for HPSE or treated with the inhibitor SST0001.
Gene and protein expression analyses revealed that H/R up-regulates the production of
both α-SMA and FN in WT tubular cells. Treatment with SST0001 significantly reduced H/R-
associated EMT, while HPSE-silenced cells exposed to H/R showed low expression level of
both EMT markers (Figs 2B, 2C and 4). Our results confirmed that protein levels of HIF-1α,
the master regulator of cell response to hypoxia, was significantly increased after hypoxia in
WT renal tubular cells. As previously reported, 24 hours after reperfusion HIF-1α levels
returned to baseline [31] (Fig 5A).
This effect was not present in cells silenced for HPSE or treated with SST0001 (Fig 5A).
Additionally, optical microscopy revealed that only wild type cells showed a morphological
change after H/R displaying an elongated phenotype (Fig 5B).
Ischemia and Reperfusion (I/R) caused HPSE up-regulation also in
animal model
To assess whether I/R was able to induce up-regulation of HPSE in vivo, we used a wild-type
(WT) mouse model in which I/R injury was induced by bilateral clamping of renal arteries for
30 min. Mice were sacrificed 48 and 72 h after I/R.
Interestingly, WT mice after 48 hours of reperfusion showed an increment of HPSE gene
expression in renal tissue (Fig 6A). However, this did not reach the statistical significance
(p = 0.08) probably because the low number of experiments.
Immunofluorescence staining of renal tissue 72 hours post-reperfusion confirmed the up-
regulation of HPSE at both glomerular and tubulointerstitial levels (Fig 6B).
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Mice over-expressing HPSE activate EMT
To assess whether an up-regulation of HPSE was able to predispose to activation of EMT pro-
gram, we used transgenic mice over-expressing HPSE (HPA-tg) and their WT littermates
undergoing I/R injury by bilateral clamping of renal arteries for 30 min. Also in this case, mice
were sacrificed 48 and 72 h after I/R.
Fig 2. Heparanase (HPSE) and epithelial to mesenchymal transition (EMT)-associated gene expression in tubular cells exposed to hypoxia
and reoxygenation (H/R).Wild type (WT) and Heparanase-silenced (HPSE-sil) HK2 cells exposed to hypoxia and reoxygenation (H/R); WT HK-2
cells were also treated or not with 200 μg/ml SST0001. Gene expression analysis of A)Heparanase (HPSE),B) alpha smooth muscle Actin (α-SMA)
andC) Fibronectin (FN) evaluated by real-time PCR. Data were normalized to GAPDH expression. NORM = normoxia. Mean ± S.D (error bars) of two
separate experiments performed in triplicate. **p<0.001, *p<0.05 vs. WT CTR NORM; ##p<0.001, # p<0.05 vsWT CTR H/R.
doi:10.1371/journal.pone.0160074.g002
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Interestingly, gene expression analysis of total kidney lysates 48 hours after I/R and immu-
nofluorescence staining for α-SMA and VIM 72 hours post-reperfusion showed that HPA-tg
mice exhibited remarkable up-regulation of these biological elements.
Instead, although we found an HPSE over-expression after I/R (Fig 6A and 6B), WT mice
showed only a slight but not statistically significant increment of the transcriptional level of
EMT markers after 48 hours and no increment in protein expression 72 hours after I/R (Fig 7).
This could be explained by the higher complexity of the in vivo EMT and pro-fibrotic biological
machinery compared to the in vitro one.
Fig 3. Heparanase (HPSE) protein expression in tubular cells exposed to hypoxia and reoxygenation
(H/R).Wild type (WT) and Heparanase-silenced (HPSE-sil) HK2 cells exposed to hypoxia and reoxygenation
(H/R); WT HK-2 cells were also treated or not with 200 μg/ml SST0001. A)Quantification of HPSE protein
levels assessed byWestern blot. GAPDH was included as loading control. NORM = normoxia.B)
Representative image of western blot experiments. **p<0.001, *p<0.05 vs. WT CTR NORM; ##p<0.001,
# p<0.05 vs WT CTR H/R.
doi:10.1371/journal.pone.0160074.g003
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In addition, since I/R is accompanied also by the activation of inflammatory response we
observed an increased macrophages infiltration in HPA-tg mice respect to wt mice 72 hours
after I/R (S1 Fig).
HPA-tg animals were more susceptible to renal function impairment
compared to wild type
To measure whether HPA-tg animals were more predisposed to develop renal function
impairment after I/R compared to WT, we measured serum-creatinine (SCr) levels in both
mice model 72 hours after this insult.
Fig 4. Epithelial to mesenchymal transition (EMT)-associated protein expression in tubular cells exposed to hypoxia and reoxygenation
(H/R).Wild type (WT) and Heparanase-silenced (HPSE-sil) HK2 cells exposed to hypoxia and reoxygenation (H/R); WT HK-2 cells were also treated
or not with 200 μg/ml SST0001. A) alpha smooth muscle Actin (α-SMA) and B) Fibronectin (FN) protein levels quantification assessed by western blot
analysis. GAPDHwas included as loading control. NORM = normoxia.C)Representative image of western blot experiments. **p<0.001, *p<0.05 vs.
WT CTR NORM; # #p<0.001 vs. WT CTR H/R. **p<0.001, *p<0.05 vs. WT CTR NORM; ##p<0.001, # p<0.05 vsWT CTR H/R.
doi:10.1371/journal.pone.0160074.g004
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Fig 5. Morphological changes in tubular cells exposed to hypoxia and reoxygenation (H/R) and Hypoxia-inducible factor 1-alpha (HIF-1α)
expression.Wild type (WT) and Heparanase-silenced (HPSE-sil) HK2 cells exposed to hypoxia and reoxygenation (H/R); WT HK-2 cells were also
treated or not with 200 μg/ml SST0001. A) HIF-1α protein levels assessed byWestern blot analysis. GAPDHwas included as loading control. NORM:
Normoxia. Representative image of western blot experiments. B) Representative images of WT cells treated or untreated with SST0001 and HPSE-
silenced HK2 cells grown on a glass surface. Cells were exposed to normoxia or 24 h hypoxia followed by 24 h reoxygenation.
doi:10.1371/journal.pone.0160074.g005
Fig 6. In vivoHeparanase (HPSE) expression induced by Ischemia and Reperfusion (I/R) kidney injury. A) Box plot representing relative gene
expression of HPSE evaluated by real-time PCR in renal tissue extract fromWild type (WT) mice. Results were normalized to GAPDH expression.
Mean ± S.E (error bars) of two separate experiments performed in triplicate.B) Representative immunofluorescence staining for HPSE in cortical
renal tissues of WTmice 72 h after sham operation or I/R kidney injury. I/R, ischemia/reperfusion.C)Quantification of the immunofluorescence
staining. **p<0.001vs. WT SHAM.
doi:10.1371/journal.pone.0160074.g006
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Interestingly, although SCr was higher in both WT and HPA-tg mice after I/R, this effect
was greater in HPA-tg mice compared to controls (Fig 8).
The structural changes in the kidney tissue of control and I/R wt and HPA-tg mice were
evaluated by PAS staining. At 48 h afterI/R, wt mice showed acute tubular necrosis which
included tubular lysis, loss of brush border and sloughed debris in tubular lumen spaces. In wt
mice the damage was partially restored after72 h (Fig 9). On the contrary, the injury in HPA-tg
mice was more profound and persistent also after 72 h. In HPA-tg mice there was a significant
alteration in glomeruli, and tubular structures. In particular, in HPA-tg mice I/R produced a
severe tubular damage with tubular dilatation, cell detachment from basement membrane, cast
formation and loss of brush border (Fig 9).
Discussion
Activated myofibroblasts in the tubular compartment of the kidney are the main producers of
collagen IV, laminin, fibronectin and are held responsible for tubular interstitial fibrosis (TIF)
[14,15]. These cells have properties similar to contractile smooth muscle cells, since they
Fig 7. Epithelial to mesenchymal transition (EMT) markers in control (SHAM)mice vs. mice after Ischemia and Reperfusion (I/R) kidney
injury. Relative gene expression of A) alpha smooth muscle Actin (α-SMA) andB) Vimentin (VIM) evaluated by real-time PCR in renal tissue extracts
fromWT and HPA-tg mice subjected to I/R kidney injury. Mean ± S.E (error bars) of two separate experiments performed in triplicate. **p<0.001 vs
WT SHAM. Representative immunofluorescence staining for C) α-SMA andD) VIM in renal tissue of WT and HPA-tg mice subjected to I/R. E)
Quantification of the immunofluorescence staining. **p<0.001vs. WT HPA-tg SHAM.
doi:10.1371/journal.pone.0160074.g007
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express α-smooth muscle actin (α-SMA) [32]. In the kidney, myofibroblasts originate from
several sources: 1) interstitial renal fibroblasts; 2) interstitial perivascular cells called pericytes;
3) fibrocytes; 4) tubular epithelial cells; and 5) endothelial cells [33,34].
Tubular epithelial-mesenchymal transition (EMT) is a process first identified in mice and,
more recently, in humans, representing an important source of these cells in the kidney, and
contributing to the onset of TIF and progression of chronic kidney disease (CKD) [35].
During this process, which ultimately determines renal fibrosis, the interstitial microenvi-
ronment is enriched with cytokines and chemokines released by the tubular epithelial cells in
response to pathological stimuli (e.g., proteinuria, high glucose concentrations, ROS, hypoxia).
Macrophages and lymphocytes attracted by chemokines release additional factors, such as
transforming growth factor-β (TGF-β), epidermal growth factor (EGF), and fibroblast growth
factor-2 (FGF-2) [13], all contributing to EMT of tubular epithelial cells.
Additionally, the aforementioned events are frequent in renal transplantation. In fact, as
demonstrated, a significant proportion of renal transplant recipients may undergo EMT and
fibrosis within a short time-period after transplantation [36]. In particular, an accelerated
fibrotic process has been reported in patients undergoing delayed graft function (DGF), a slow
recovery of renal function that requires dialysis treatment after transplantation [37].
DGF is a multi-factorial event influenced by several clinical factors (e.g., kidneys from non-
heart-beating donor, inotropic support of the donor), donor characteristics (e.g., age, diabetes,
hypertension), recipients conditions (e.g., pre-transplant dialysis treatment, number of previ-
ous transplants, allosensitization) and length of cold ischemia time [38]. The latter (ischemia/
Fig 8. Renal function in Wild Type (WT) and HPA-tg mice subjected to Ischemia and Reperfusion (I/R). Effects of Acute
kidney Injury (AKI) on serum creatinine (SCr) after I/R insult in WT and HPA-Tg mice. Results are expressed as Mean±SEM.
*p<0.05, **p<0.001 vs. SHAM; ##p<0.001vs. WT I/R 72 h.
doi:10.1371/journal.pone.0160074.g008
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reperfusion (I/R) injury) induces local and systemic biological/cellular events, which are
responsible for EMT and subsequently the development of chronic graft dysfunction [39].
Several recent findings indicate that HPSE is involved in the pathogenesis of renal fibrosis
[16] in proteinuric disease such as diabetic nephropathy [20,22]. Interestingly, we have shown
that this could be attributed to a pivotal leading role of HPSE in the regulation of EMT in tubu-
lar cells [24,25].
At the present time, however, no studies have defined the contribution of HPSE in H/R-
associated renal injury. Only one report has shown a possible contribution of this enzyme to
the onset of sepsis-induced AKI [23]. We hypothesized that HPSE is triggered in I/R renal
injury and plays a role in the pathogenesis of I/R renal injury and in eliciting EMT. This could
lead to the development of renal fibrosis and long-term renal dysfunction in the allograft.
In this study we have demonstrated in vitro and in vivo that HPSE is upregulated in I/R
renal injury. The data also suggest that HPSE may contribute to EMT induction of tubular
cells, thereby contributing to the development of organ fibrosis.
By using HK-2 cells, a human immortalized proximal tubular cell line, we provided evidence
that H/R up-regulates HPSE gene expression (Fig 2A) and protein synthesis (Fig 2B). The kid-
ney has an efficient protecting system against hypoxia and the Hypoxia-Inducible Factor (HIF)
is the “Master Gene” in this system [40]. HPSE is associated with HIF-1α expression [36],
which is constitutively expressed in tubular cells. In fact, HPSE silencing was shown to be
Fig 9. Ischemia and Reperfusion (I/R) kidney injury in wild type (wt) and HPA-tg mice. I/R kidney injury
was induced in wt and HPA-tg mice by clamping of both renal arteries for 30 minutes. Mice were sacrificed
after 48 or 72 hours. Shown are representative images of PAS staining of paraffin-embedded cortex and
medulla sections from various experimental groups. Magnification 40X. I/R, ischemia/reperfusion.
doi:10.1371/journal.pone.0160074.g009
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associated with decreased HIF-1α level [41], suggesting that HIF-1α is downstream to HPSE.
Our results confirmed that, as previously described, during H/R HIF-1a is upregulated in the
hypoxic phase in tubular cells and this event could be responsible for modulation of gene
expression [31] and activation of EMT via Bmi and PI3K/AKT pathway [42]. We proved that
the silencing and the inhibition of heparanase prevent the accumulation of HIF-1α thus this
could be a possible mechanism of EMT regulation in tubular cells
Interestingly, we observed that the HPSE inhibitor SST0001 down-regulates HPSE expres-
sion. We supposed that reduced HPSE activity upregulates the nuclear content of heparan sul-
phate and syndecan-1, which in turn modulates histone acetyltransferase activity [43].
However in our cellular model we observed that the treatment with SST0001 did not induce
significant changes in syndecan-1 expression (S2 Fig) thus future studies will be necessary to
explain this phenomenon.
We confirmed the results obtained in cell culture in a mouse model of I/R kidney injury.
Indeed, in mice subjected to 30 minutes of renal ischemia followed by reperfusion, we detected
over expression of the HPSE gene (Fig 6A) and HPSE deposition at both glomerular and
tubulo-interstitial levels (Fig 6B).
The pathogenesis of I/R renal injury is very complex and includes a strong inflammatory
response occurring following reperfusion due to leukocyte infiltration and activation [6]. How-
ever, the correspondence of the in vitro with the in vivo results suggests that the main trigger is
hypoxia per se. Whether cell infiltration is involved in HPSE-dependent EMT of tubular cells
requires further studies.
As expected, the EMT transcriptional program was activated after H/R (Fig 3). These modi-
fications occurred in parallel with morphological changes in WT tubular cells. Specifically, the
latter lost their typical cobblestone epithelial phenotype becoming elongated like fibroblasts.
HPSE seems to play a major role in these processes. In fact, HPSE-silenced cells and WT
tubular cells treated with SST0001 maintained a normal epithelial phenotype after both hyp-
oxia and reoxygenation, and did not initiate the EMT transcriptional program as demonstrated
by stable levels of FN and α-SMA.
SST0001, a potent heparin-like inhibitor of heparanase enzyme activity, markedly decreased
the ability of HPSE to release and potentiate the activity of extracellular matrix-bound FGF-2
as compared to unmodified heparin. Moreover, glycol-splitting causes heparin to lose its affin-
ity to anti-thrombin, resulting in loss of anticoagulant activity. Collectively, the combination of
high inhibition of heparanase, low release/potentiation of ECM-bound growth factors and the
lack of anticoagulant activity points to N-acetylated, glycol-split heparins (e.g., SST0001) as
potential anti-fibrotic, anti-angiogenic and anti-metastatic agents [44].
To the best of our knowledge this is the first evidence that HPSE is involved in H/R injury
in renal tubular cells. We applied HPSE over-expressing mice presuming that in this model the
biological consequences of HPSE would be magnified. As a matter of fact this hypothesis was
confirmed by our experimental findings. Thus, the renal pathology in HPA-tg mice following
I/R was more severe than in their wt littermates. In particular HPA-tg mice exhibited more
tubular dilatation, cell detachment from basement membrane, cast formation and loss of brush
border. In addition, HPA-tg mice displayed higher levels of serum creatinine following renal
I/R as compared with WTmice subjected to the same procedure (Fig 8). The role of HPSE as
regulator of EMT in H/R was evident also in I/R in vivo. Indeed I/R kidney injury induced a
rapid up-regulation of mesenchymal markers (i.e., α-SMA and VIM) in renal tissues of HPA-
tg mice, but not in WT animals where only a faint trend could be observed. HPSE overexpres-
sion was also associated with increased macrophages infiltration, one other pathological event
that occurred in I/R [45] (S1 Fig).
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It is not known if the role of HPSE in acute I/R also occurs in long term ischemia observed
in CKD. If this is the case, then inhibition of HPSE may be a novel therapeutic approach to pre-
vent CKD progression and worth further investigation. In humans, it has been shown that a
significant proportion of kidney recipients display EMT features short time after organ trans-
plantation [46], suggesting that risk factors and/or molecular events may regulate the onset of a
fibrotic progression. The present data suggest that overexpression of HPSE during the ischemic
events could represent a predisposing factor for activation of the EMT program. Furthermore,
our in vitro results clearly indicate that inhibition of HPSE with SST0001 can reduce the EMT
activation induced by H/R. This effect seemed more pronounced when the inhibitor was
administered before hypoxia. In this perspective HPSE-inhibiting strategies could be useful
both after the ischemic insult for a curative intent, but also before a “planned” ischemic event
such as kidney transplantation. However, a major limitation of our study is the lack of in vivo
testing of protective effect of SST0001 after H/R. Future studies should be undertaken to assess
this objective.
Collectively, our results indicate that HPSE is a pivotal factor for the development of ische-
mia/reperfusion-induced EMT and its inhibition may represent a new valuable therapeutic
approach to minimize or prevent fibrosis in native or transplanted kidneys.
Supporting Information
S1 Fig. Syndecan 1 (SDC-1) gene expression in tubular cells exposed to hypoxia and reoxy-
genation (H/R) and different SST0001 concentrations.Wild type (WT) and Heparanase-
silenced (HPSE-sil) HK2 cells exposed to hypoxia and reoxygenation (H/R); WT HK-2 cells
were also treated or not with 200 μg/ml SST0001. Gene expression analysis of SDC-1 evaluated
by real-time PCR. Data were normalized to GAPDH expression. NORM = normoxia.
Mean ± S.D (error bars) of two separate experiments performed in triplicate. p<0.001 vs.
WT CTR NORM.
(TIF)
S2 Fig. Representative immunofluorescence staining for the specific macrophage-restricted
F4/80 protein in renal tissue of Wild Type (WT) and HPA-tg mice subjected to Ischemia
and Reperfusion (I/R).
(TIF)
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